Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds,Leeds,UK.
Proc Nutr Soc. 2016 Nov;75(4):512-520. doi: 10.1017/S002966511600063X. Epub 2016 Jun 23.
Sleep curtailment is common in the Westernised world and coincides with an increase in the prevalence of type 2 diabetes mellitus (T2DM). This review considers the recently published evidence for whether sleep duration is involved in the development of T2DM in human subjects and whether sleep has a role to play in glucose control in people who have diabetes. Data from large, prospective studies indicate a U-shaped relationship between sleep duration and the development of T2DM. Smaller, cross-sectional studies also support a relationship between short sleep duration and the development of both insulin resistance and T2DM. Intervention studies show that sleep restriction leads to insulin resistance, with recent sleep extension studies offering tantalising data showing a potential benefit of sleep extension on glucose control and insulin sensitivity. In people with established diabetes the published literature shows an association between poor glucose control and both short and long sleep durations. However, there are currently no studies that determine the causal direction of this relationship, nor whether sleep interventions are likely to offer benefit for people with diabetes to help them achieve tighter glucose control.
睡眠不足在西方世界很常见,且与 2 型糖尿病(T2DM)的发病率上升有关。本综述考虑了最近发表的关于睡眠持续时间是否与人类 T2DM 发病有关的证据,以及睡眠在糖尿病患者的血糖控制中是否发挥作用。来自大型前瞻性研究的数据表明,睡眠持续时间与 T2DM 的发生之间呈 U 形关系。较小的横断面研究也支持短睡眠时间与胰岛素抵抗和 T2DM 发生之间存在关系。干预研究表明,睡眠限制会导致胰岛素抵抗,最近的睡眠延长研究提供了诱人的数据,表明睡眠延长可能对血糖控制和胰岛素敏感性有益。在已确诊糖尿病的人群中,已发表的文献表明,血糖控制不佳与短时间和长时间睡眠之间存在关联。然而,目前尚无研究确定这种关系的因果方向,也无法确定睡眠干预是否可能为糖尿病患者带来益处,帮助他们实现更严格的血糖控制。